These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 20960417

  • 21. A comparison of dorzolamide-timolol combination versus the concomitant drugs.
    Choudhri S, Wand M, Shields MB.
    Am J Ophthalmol; 2000 Dec; 130(6):832-3. PubMed ID: 11124307
    [Abstract] [Full Text] [Related]

  • 22. The effects of topical dorzolamide 2% and brinzolamide 1%, either alone or combined with timolol 0.5%, on intraocular pressure, pupil diameter, and heart rate in healthy cats.
    Slenter IJM, Djajadiningrat-Laanen SC, Elders DJ, de Gee R, Koele LE, Vermeer LW, Boevé MH.
    Vet Ophthalmol; 2020 Jan; 23(1):16-24. PubMed ID: 31099474
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH, Feldman RM, Sheu WP, Fixed Combination Latanoprost/Timolol Study Group.
    Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
    [Abstract] [Full Text] [Related]

  • 24. Effect of dorzolamide and timolol on ocular blood flow in patients with primary open angle glaucoma and ocular hypertension.
    Fuchsjäger-Mayrl G, Wally B, Rainer G, Buehl W, Aggermann T, Kolodjaschna J, Weigert G, Polska E, Eichler HG, Vass C, Schmetterer L.
    Br J Ophthalmol; 2005 Oct; 89(10):1293-7. PubMed ID: 16170119
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparison of the efficacy of betaxolol-brinzolamide and timolol-dorzolamide as suppressors of aqueous humor flow in human subjects.
    Brubaker RF, Ingram CJ, Schoff EO, Nau CB.
    Ophthalmology; 2000 Feb; 107(2):283-7. PubMed ID: 10690826
    [Abstract] [Full Text] [Related]

  • 27. Continuous intraocular pressure measurement by telemetry in alpha-chymotrypsin-induced glaucoma model in the rabbit: effects of timolol, dorzolamide, and epinephrine.
    Percicot CL, Schnell CR, Debon C, Hariton C.
    J Pharmacol Toxicol Methods; 1996 Dec; 36(4):223-8. PubMed ID: 9040114
    [Abstract] [Full Text] [Related]

  • 28. Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension.
    Balfour JA, Wilde MI.
    Drugs Aging; 1997 May; 10(5):384-403. PubMed ID: 9143858
    [Abstract] [Full Text] [Related]

  • 29. Optic nerve oxygen tension: the effects of timolol and dorzolamide.
    Kiilgaard JF, Pedersen DB, Eysteinsson T, la Cour M, Bang K, Jensen PK, Stefánsson E.
    Br J Ophthalmol; 2004 Feb; 88(2):276-9. PubMed ID: 14736791
    [Abstract] [Full Text] [Related]

  • 30. Pharmacodynamic equivalence study of two preparations of eye drops containing dorzolamide and timolol in healthy volunteers.
    Gatchev E, Petrov A, Kolev E, Hristova R, Demircheva I, Koytchev R, Richter W, Tegel F, Thyroff-Friesinger U.
    Arzneimittelforschung; 2011 Feb; 61(5):282-6. PubMed ID: 21755811
    [Abstract] [Full Text] [Related]

  • 31. The effect of timolol-dorzolamide and timolol-pilocarpine combinations on ocular blood flow in patients with glaucoma.
    Uva MG, Longo A, Reibaldi M, Reibaldi A.
    Am J Ophthalmol; 2006 Jun; 141(6):1158-60. PubMed ID: 16765700
    [Abstract] [Full Text] [Related]

  • 32. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M, Grigera DE, Barbosa WL, Jordao M, Susanna R.
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [Abstract] [Full Text] [Related]

  • 33. [Trusopt--a new form of drug for treating glaucoma].
    Izdebska J.
    Klin Oczna; 1997 Dec; 99(3):217-20. PubMed ID: 9456571
    [Abstract] [Full Text] [Related]

  • 34. Brinzolamide 1%/timolol 0.5%: safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma.
    Januleviciene I.
    Curr Med Res Opin; 2010 Nov; 26(11):2575-8. PubMed ID: 20868340
    [Abstract] [Full Text] [Related]

  • 35. Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs.
    Cawrse MA, Ward DA, Hendrix DV.
    Am J Vet Res; 2001 Jun; 62(6):859-63. PubMed ID: 11400841
    [Abstract] [Full Text] [Related]

  • 36. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
    Janulevicienë I, Harris A, Kagemann L, Siesky B, McCranor L.
    Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
    [Abstract] [Full Text] [Related]

  • 37. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group.
    Adamsons I, Clineschmidt C, Polis A, Taylor J, Shedden A, Laibovitz R.
    J Glaucoma; 1998 Aug; 7(4):253-60. PubMed ID: 9713783
    [Abstract] [Full Text] [Related]

  • 38. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA, Polis A, Ostrov CS, Boyle JE.
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [Abstract] [Full Text] [Related]

  • 39. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M, Reis A, Sano ME, Susanna R.
    J Glaucoma; 2010 Dec; 19(5):331-5. PubMed ID: 19730119
    [Abstract] [Full Text] [Related]

  • 40. The effects of a fixed combination of 0.5% timolol and 1% dorzolamide on optic nerve head blood circulation.
    Ohguro I, Ohguro H.
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):392-6. PubMed ID: 22480163
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.